April 30, 2024

Business Active

business the management

Briefs on local businesspeople, including Martin Kessler, Toni N. Travaglini, Andrew Kantorski and Stephan MacPhee.

45 min read

Rentschler Biopharma SE, a global contract development and manufacturing organization for biopharmaceuticals, has appointed Martin Kessler as CEO of Rentschler Biopharma Inc., the company’s wholly owned U.S. subsidiary, and as senior vice president transformation of Rentschler Biopharma SE.

Martin Kessler

Kessler brings more than 15 years of experience in pharmaceutical and biopharmaceutical operations and strategy. At Rentschler Biopharma, he will drive the transformation throughout the company as it grows strategically into new fields and technologies. In his role as head of the U.S. business, he will lead the ongoing expansion at the company’s Greater Boston area site, which includes expanding capabilities, capacity and talent.

Kessler held several leadership positions in the industry and in the consulting business before joining Rentschler Biopharma. In his last position, he was associate partner at McKinsey & Company and led the medical device operations practice in Europe. He served leading pharma, biopharma, and med-tech companies in optimizing operations, specifically, supply chain, manufacturing and quality. He brings additional expertise in strategy and portfolio optimization, as well as clinical development, including in the mRNA space.

You may have missed